MSB 0.36% $1.38 mesoblast limited

Besides the obvious big ones in partnerships, FDA approval or...

  1. 112 Posts.
    lightbulb Created with Sketch. 30

    Besides the obvious big ones in partnerships, FDA approval or major trial results, an update from Tasly, FDA guidance with LVAD, Tiginex income.

    We could get left field results from boston children's hospital trial for kids with HLHS,
    Some more info from the mesoblast/cartherics collaboration or a cheeky partner to kick off RA phase 3.

    Can I just say this ongoing major partnership talk is cruel. The cash situation is starting to squeeze, again. While the lack off commitment from a major partner that provides funds and vindication of the science is something that's starting to weigh on my conviction that SI can be trusted.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Mkt cap ! $683.1M
Open High Low Value Volume
$1.37 $1.38 $1.37 $363.0K 264.3K

Buyers (Bids)

No. Vol. Price($)
5 4688 $1.37

Sellers (Offers)

Price($) Vol. No.
$1.38 7676 4
View Market Depth
Last update - 12.58pm 20/06/2019 (20 minute delay) ?
0.005 ( 0.21 %)
Open High Low Volume
$1.38 $1.38 $1.37 41893
Last updated 13.13pm 20/06/2019 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.